Wei Lu
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Cancer Research top 2%
Papers in
-
- Metabolism, Diabetes, and Cancer 11
- Genetics 65
- Diabetes and associated disorders 31
- Genetic Associations and Epidemiology 11
- Co-authors
- Wei Zheng (42 shared papers)Kai Gu (30 shared papers)Jian Zhou (59 shared papers)Xiao‐Ou Shu (29 shared papers)Xiao Ou Shu (24 shared papers)Qiuyin Cai (30 shared papers)Ying Zheng (24 shared papers)Jingyi Lu (40 shared papers)
- Journals
- Breast Cancer Research and Treatment (14 papers)Cancer Research (8 papers)American Journal of Epidemiology (7 papers)Cancer Causes & Control (6 papers)Cancer Epidemiology Biomarkers & Prevention (6 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Wei Lu
251 papers receiving 6.4k citations
Wei Lu's Hit Papers
Peers
Comparison fields: 5 of 167
- Endocrinology, Diabetes and Metabolism 1.3k
- Cancer Research 1.0k
- Oncology 1.7k
- Genetics 1.4k
- Pathology and Forensic Medicine 551
Countries citing papers authored by Wei Lu
This map shows the geographic impact of Wei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lu more than expected).
Fields of papers citing papers by Wei Lu
This network shows the impact of papers produced by Wei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lu. The network helps show where Wei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes Hit paper breakdown → | 2018 | 355 |
| 2 | 2009 | 353 | |
| 3 | 2020 | 174 | |
| 4 | 2019 | 149 | |
| 5 | 2010 | 148 | |
| 6 | 2011 | 136 | |
| 7 | 2010 | 133 | |
| 8 | 2020 | 126 | |
| 9 | 2012 | 122 | |
| 10 | 2011 | 115 | |
| 11 | 2015 | 103 | |
| 12 | 2013 | 103 | |
| 13 | 2011 | 102 | |
| 14 | 2011 | 91 | |
| 15 | 2008 | 87 | |
| 16 | 2010 | 78 | |
| 17 | 2009 | 77 | |
| 18 | 2010 | 75 | |
| 19 | 2011 | 74 | |
| 20 | 2017 | 72 |
About Wei Lu
Wei Lu is a scholar working on Molecular Biology, Genetics, Endocrinology, Diabetes and Metabolism, Surgery and Oncology, having authored 259 papers that have together received 6.5k indexed citations. Recurring topics across this work include Diabetes Management and Research (41 papers), Diabetes and associated disorders (31 papers), Cancer Risks and Factors (24 papers), Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (14 papers), Genetic Associations and Epidemiology (11 papers), Metabolism, Diabetes, and Cancer (11 papers) and Cancer survivorship and care (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Cancer Research (1.0k citations), Oncology (1.7k citations), Genetics (1.4k citations) and Pathology and Forensic Medicine (551 citations). Wei Lu has collaborated with scholars based in China, United States and India. Frequent co-authors include Wei Zheng, Kai Gu, Jian Zhou, Xiao‐Ou Shu, Xiao Ou Shu, Qiuyin Cai, Ying Zheng, Jingyi Lu, Yuqian Bao and Wei Zhu. Their work appears in journals such as Breast Cancer Research and Treatment, Cancer Research, American Journal of Epidemiology, Cancer Causes & Control and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.